Alexion Pharmaceuticals, Inc.

Tredje AP-fonden ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/6/2021

Shares

25,038

Value ($000)

4,600

Weight

0.1%

2019 Q4 - 2021 Q2 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/6/2021	4,600	0.1%	25,038	6/30/2021
2021 Q1	5/10/2021	3,829	0.1%	25,038	3/31/2021
2020 Q4	2/12/2021	3,912	0.1%	25,038	12/31/2020
2020 Q3	11/10/2020	2,865	0.1%	25,038	9/30/2020
2020 Q2	8/11/2020	2,810	0.1%	25,038	6/30/2020
2020 Q1	5/28/2020	3,890	0.2%	43,326	3/31/2020
2019 Q4	2/10/2020	4,394	0.2%	40,633	12/31/2019